Skip to content
Search

Latest Stories

Layla Moran wants update on pharmacy economic review

Layla Moran wants update on pharmacy economic review

Layla Moran

Ministers have asked NHS England to provide an update on when the economic review into pharmacy as unrest continues to grow in the delay in publishing the report.

The NHS England-commissioned independent report aims to analyse pharmacy funding and the cost of delivering NHS services.


Led by Layla Moran, chair of the Health and Social Care Committee (HSCC) and MP for Oxford Wes and Abingdon, a letter has been sent to outgoing NHS England chief executive Amanda Pritchard asking when the report will be released and if it will be published in full.

Commenting on the letter, Nick Kaye, chair of the National Pharmacy Association (NPA) said:

"We're pleased to see that the Health Select Committee is seeking an urgent update on the full publication of the Independent Economic Analysis.

"The NPA has called for much needed transparency - there is no reason why this document cannot be published immediately.

"It is vitally important the public can fully understand the financial pressures affecting community pharmacy before any offer is put forward by the government."

Last week, pharmacy minister Stephen Kinnock revealed that work on the economic reviews was “nearing completion and will be published at the earliest opportunity”.

Community Pharmacy England (CPE) said they had considered draft findings of the review and had submitted further comments to the report’s authors last week. They added that they will consider the final report once completed, as part of the ongoing negotiation process for the community pharmacy funding contract.

In a statement, NHS England said whilst it was committed to publishing the report, they were unable to give further details whilst consultations are ongoing with Community Pharmacy England over 2024/25 and 2025/26 funding arrangements.

More For You

Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
The Realities of Dementia Care for Families

The Realities of Dementia Care for Families

Caring for a loved one with dementia is a journey that presents both emotional and practical challenges for families. Dementia, a progressive condition affecting memory, cognition, and behaviour, requires long-term care strategies and significant emotional resilience. Understanding the realities of dementia care can help families prepare and ensure their loved ones receive the best possible support.

1. The Emotional Toll on Families

Keep ReadingShow less
Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less